SecBot SecBot

GELS

Gelteq Ltd
Nasdaq· Pharmaceutical Preparations· Inc. C3· CIK 0001920092 Biotech & Drug Discovery
$0.4583 +0.01 (+2.53%)
Oct 27 4:00 PM ET · prev $0.4470
Market cap
$4.6M
Nano cap
Next earnings
Nov 16
in 20 days
1 year
−62.4%
from $1.22 · Oct 28
30 days
−16.2%
from $0.5470
52-week range
$0.3900–1.53
−70% from high · low May 19
Avg volume 20D
95.2K
Oct 26 spike 823.1K
Short interest
314.6K
≈2.9% of shares · −39.6%
Days to cover
4.8
at average volume
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
2
analyzed by SecBot
SecBot read BEARISH 1 report · latest
Balance 1 bearish · 0 bullish oldest → newest, height = score
Avg score ·High conf. 1/1 ·Next Earnings date, Nov 16, 2026
Strongest BEARISH Gelteq's 6-K filing for H1 FY2026 reveals a critical liquidity crisis: cash and cash equivalents collapsed…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q2 2026: 0 added (0 new), 1 trimmed or exited.

  • Short sellersCOVERING

    Short interest −39.6% to 314.6K shares. 4.8 days to cover, ≈2.9% of shares.

  • TrendDOWNTREND

    19% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
UBS Group AGNEAR_EXIT125$83.00

Quarterly 13F filings are due 45 days after each quarter ends.

Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 16, 2026
Earnings date
GELS Q4 2026 Earnings Scheduled — 2026-11-16
Recent
Sep 22, 2026
Trading halt
Halt Resumed: GELS — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-09-22T15:27:45.000Z | Resumed 2026-09-22T15:32:45.000Z
Sep 22, 2026
Trading halt
Trading Halt: GELS — LUDP (Volatility Trading Pause)
Gelteq Limited Ordinary Shares | Market: NASDAQ | Code: LUDP — Volatility Trading Pause
Sep 3, 2026
Trading halt
Halt Resumed: GELS — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-09-03T13:38:28.000Z | Resumed 2026-09-03T13:43:28.000Z
Sep 3, 2026
Trading halt
Trading Halt: GELS — LUDP (Volatility Trading Pause)
Gelteq Limited Ordinary Shares | Market: NASDAQ | Code: LUDP — Volatility Trading Pause
Jun 22, 2026
Earnings date
GELS Q2 2026 Earnings Scheduled — 2026-06-22

Earnings setup

Estimates
Nov 16
reports in 20 days
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Oct 15, 2026
314,643
shares short
-39.6%
vs prior settlement
4.8
days to cover
≈2.9%
of shares outstanding
Trading halts
Sep 22, 2026Volatility PauseResumed
Sep 3, 2026Volatility PauseResumed
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 22, 2026 Trading halt
Halt Resumed: GELS — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-09-22T15:27:45.000Z | Resumed 2026-09-22T15:32:45.000Z
Jun 30, 2026 SEC
Gelteq's 6-K filing for H1 FY2026 reveals a critical liquidity crisis: cash and cash equivalents collapsed to just AUD…
6-K — Impact 7/10
Jun 30, 2026 Inst.
UBS Group AG — NEAR_EXIT
125 shares ($83.00)
Jun 17, 2026 Press
Gelteq provided a corporate update on its pipeline progress, including plans to commence a human clinical trial in Q3…
Impact 3/10
Jun 12, 2026 Press
Gelteq announced successful veterinary palatability trials with Kemin Industries, validating its gel-based drug…
Impact 4/10
Jun 2, 2026 SEC
Gelteq is holding a special shareholder meeting on June 19, 2026, to seek approval under Nasdaq Listing Rule 5635(d)…
6-K — Impact 7/10

SecBot reports

2 filings · 2 press releases · 0 bullish · 2 bearish
All GELS filing & press-release reports (4)